Profound Medical Annual and Special Meeting of Shareholders Voting Results
17 mai 2023 16h15 HE
|
Profound Medical Corp.
TORONTO, May 17, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual and Special Meeting...
Profound Medical Announces First Quarter 2023 Financial Results
10 mai 2023 16h05 HE
|
Profound Medical Corp.
TORONTO, May 10, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting
01 mai 2023 16h30 HE
|
Profound Medical Corp.
– Presentations reinforce the safety, efficacy and durability of the TULSA procedure, further supporting its potential as a mainstream, whole gland or focal treatment for prostate disease – – FARP...
Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow
19 avr. 2023 16h30 HE
|
Profound Medical Corp.
TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
19 avr. 2023 16h15 HE
|
Profound Medical Corp.
TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results
07 mars 2023 16h05 HE
|
Profound Medical Corp.
TORONTO, March 07, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Present at the 43rd Annual Cowen Health Care Conference
01 mars 2023 16h30 HE
|
Profound Medical Corp.
TORONTO, March 01, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 – Conference Call to Follow
14 févr. 2023 16h30 HE
|
Profound Medical Corp.
TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Present at the 2022 Jefferies London Healthcare Conference
08 nov. 2022 16h30 HE
|
Profound Medical Corp.
TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Third Quarter 2022 Financial Results
03 nov. 2022 16h05 HE
|
Profound Medical Corp.
TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...